Full name
LIPID SYSTEMS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Scientific research and development activities
10.89.Z - Production of other food products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
71.12.Z - Engineering activities and related technical consultancy
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -1 | 4,2 | 1,7 | -59,7 |
EBITDA | 0,4 | 5,5 | 2,7 | -50,7 |
Short time liabilities | 3,8 | 4,6 | 3,4 | -27,1 |
Equity capital | 30,6 | 34,9 | 36,5 | 4,3 |
Operating profit (EBIT) | -0,3 | 4,8 | 2,1 | -56,7 |
Assets | 56,7 | 61,1 | 58,3 | -4,5 |
Net profit (loss) | -0,8 | 4,3 | 1,5 | -64,9 |
Cash | 1,3 | 2,2 | 2 | -9,2 |
Net income from sale | 8,6 | 16,9 | 9,3 | -44,9 |
Liabilities and provisions for liabilities | 26 | 26,1 | 21,9 | -16,3 |
Working assets | 4,2 | 8,7 | 4 | -53,9 |
Depreciation | 0,6 | 0,7 | 0,6 | -8,7 |
% | % | % | p.p. | |
Profitability of capital | -2,7 | 12,4 | 4,2 | -8,2 |
Equity capital to total assets | 54 | 57,2 | 62,5 | 5,3 |
Gross profit margin | -11,2 | 25,1 | 18,4 | -6,7 |
EBITDA Margin | 4,3 | 32,6 | 29,2 | -3,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 160 | 100 | 132 | 32 |
Current financial liquidity indicator | 0.5945736169815063 | 1.1104049682617188 | 0.6090252995491028 | -0,5 |
Net dept to EBITDA | 48.37446975708008 | 2.9220468997955322 | 4.879881381988525 | 2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane